David Rabkin

David Rabkin, MD, is an Associate Professor in the Department of Cardiothoracic Surgery at the School of Medicine, Loma Linda University. He is actively involved in clinical research, surgical innovation, and academic leadership in cardiothoracic surgery.

Research Interests: Dr. Rabkin’s research spans heart transplantation, cardiac surgery outcomes, mechanical circulatory support, valvular and coronary disease, and surgical techniques. His work emphasizes improving patient outcomes through data analysis, policy evaluation, and translational research. He frequently investigates the impact of new allocation systems, surgical innovations like del Nido cardioplegia, and the effects of comorbidities such as HIV and methamphetamine use on surgical results.

Recent Research Trends: His recent publications (2021–2024) demonstrate a strong focus on heart transplant allocation policy, donor heart utilization, outcomes in CABG and valve surgery, and rare cardiac pathologies. He utilizes large databases (e.g., UNOS) and conducts single-center retrospective studies to analyze clinical outcomes and inform practice.

Grants and Research Projects: Dr. Rabkin is actively leading multiple research initiatives. He serves as Principal Investigator (PI) or PD/PI on several grants, including projects on tissue engineering for cardiovascular repair, impact of methamphetamine use on aortic dissection, low-dose anticoagulation with On-X® valve, and the TRAC-AF Registry. His research is funded by industry partners like Artivion and AtriCure Inc., as well as internal university sources.

Professional Affiliations: He is an active member of leading professional societies, including:

• American College of Surgeons (2013–Present)
• The Society of Thoracic Surgeons (2010–Present)
• International Society for Heart and Lung Transplantation (2010–Present)
• American Heart Association (Present)

Clinical and Academic Leadership: His role as PI on numerous studies and his sustained publication record in high-impact journals underscore his leadership in cardiothoracic research. He collaborates extensively with colleagues across departments, particularly in surgery, pathology, and medicine.